?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

News

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
June 30, 2023 signalgroup
Delivering on a Watershed Moment for Biosimilars and Patients
News
April 10, 2023 signalgroup
Biosimilars Key to Lowering Healthcare and Prescription Drug Costs, According to Employers
News
March 30, 2023 signalgroup
Biosimilars Forum Applauds the U.S. Senate Finance Committee for Holding PBMs Accountable for Prioritizing Profits over Patients
News
March 3, 2023 signalgroup
Biosimilars Forum Applauds Congressman Hudson for Supporting Biosimilars Through Shared Savings Legislation
News
January 31, 2023 signalgroup
The Biosimilars Forum Calls on Decisionmakers to Deliver on Humira Biosimilars
News
November 10, 2022 signalgroup
Dorothy McCabe Member Spotlight
News
November 3, 2022 signalgroup
Biosimilars Forum Wins Global Biosimilars Industry Partner of the Year at Global Generics & Biosimilars Awards
News
October 4, 2022 signalgroup
Biosimilars Forum Applauds CMS Biosimilars Measure
News
October 4, 2022 signalgroup
Inflation Reduction Act – ASP+8 Biosimilars Payment Increase
News
September 20, 2022 signalgroup
ASP +8: CMS Releases Biosimilars Information
  • Prev page
  • 02
  • 03
  • 04
  • 05
  • 06
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us